D
DOXIMITY INC
NYSE: DOCS (Doximity, Inc.)
Last update: 2 days ago, 9:05PM25.02
0.31 (1.25%)
| Previous Close | 24.71 |
| Open | 25.17 |
| Volume | 3,724,603 |
| Avg. Volume (3M) | 3,461,620 |
| Market Cap | 4,710,546,944 |
| Price / Earnings (TTM) | 21.03 |
| Price / Earnings (Forward) | 16.13 |
| Price / Sales | 8.74 |
| Price / Book | 5.23 |
| 52 Weeks Range | |
| Earnings Date | 5 Feb 2026 |
| Profit Margin | 39.13% |
| Operating Margin (TTM) | 35.32% |
| Diluted EPS (TTM) | 1.11 |
| Quarterly Revenue Growth (YOY) | 17.10% |
| Quarterly Earnings Growth (YOY) | 53.80% |
| Total Debt/Equity (MRQ) | 1.15% |
| Current Ratio (MRQ) | 6.97 |
| Operating Cash Flow (TTM) | 273.26 M |
| Levered Free Cash Flow (TTM) | 216.76 M |
| Return on Assets (TTM) | 12.31% |
| Return on Equity (TTM) | 22.50% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | Doximity, Inc. | Bearish | Bearish |
AIStockmoo Score
0.6
| Analyst Consensus | 1.0 |
| Insider Activity | 1.5 |
| Price Volatility | 3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.60 |
|
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 2.24% |
| % Held by Institutions | 93.70% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 65.00 (Raymond James, 159.79%) | Buy |
| Median | 40.00 (59.87%) | |
| Low | 34.00 (Mizuho, 35.89%) | Hold |
| 34.00 (Canaccord Genuity, 35.89%) | Buy | |
| 34.00 (Goldman Sachs, 35.89%) | Hold | |
| Average | 44.69 (78.62%) | |
| Total | 10 Buy, 3 Hold | |
| Avg. Price @ Call | 30.50 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 11 Feb 2026 | 38.00 (51.88%) | Buy | 25.96 |
| 09 Dec 2025 | 63.00 (151.80%) | Buy | 45.13 | |
| Mizuho | 10 Feb 2026 | 34.00 (35.89%) | Hold | 27.24 |
| Canaccord Genuity | 09 Feb 2026 | 34.00 (35.89%) | Buy | 27.50 |
| Goldman Sachs | 09 Feb 2026 | 34.00 (35.89%) | Hold | 27.50 |
| BTIG | 06 Feb 2026 | 50.00 (99.84%) | Buy | 27.73 |
| JP Morgan | 06 Feb 2026 | 40.00 (59.87%) | Hold | 27.73 |
| Morgan Stanley | 06 Feb 2026 | 49.00 (95.84%) | Buy | 27.73 |
| 15 Dec 2025 | 65.00 (159.79%) | Buy | 44.65 | |
| Needham | 06 Feb 2026 | 55.00 (119.82%) | Buy | 27.73 |
| Piper Sandler | 06 Feb 2026 | 40.00 (59.87%) | Buy | 27.73 |
| Truist Securities | 06 Feb 2026 | 37.00 (47.88%) | Buy | 27.73 |
| Wells Fargo | 06 Feb 2026 | 45.00 (79.86%) | Buy | 27.73 |
| 20 Jan 2026 | 55.00 (119.82%) | Buy | 41.10 | |
| Keybanc | 08 Jan 2026 | 60.00 (139.81%) | Buy | 43.74 |
| Raymond James | 21 Nov 2025 | 65.00 (159.79%) | Buy | 50.42 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| WAMPLER KIRA SCHERER | 37.29 | 37.29 | 0 | 0 |
| Aggregate Net Quantity | 0 | |||
| Aggregate Net Value ($) | 0 | |||
| Aggregate Avg. Buy ($) | 37.29 | |||
| Aggregate Avg. Sell ($) | 37.29 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| WAMPLER KIRA SCHERER | Director | 02 Feb 2026 | Acquired (+) | 2,000 | 37.29 | 74,580 |
| WAMPLER KIRA SCHERER | Director | 02 Feb 2026 | Automatic sell (-) | 2,000 | 37.29 | 74,580 |
| Date | Type | Details |
|---|---|---|
| 05 Feb 2026 | Announcement | Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year |
| 05 Feb 2026 | Announcement | Doximity Announces Fiscal 2026 Third Quarter Financial Results |
| 15 Jan 2026 | Announcement | Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |